ODDB.org: Open Drug Database

Swissmedic Registration	70493	Date of registration	02.06.2026
Company name	Sandoz Pharmaceuticals AG	Revision date
		Valid until	01.06.2031
Indication		Date of market entry
Index Therapeuticus (BSV)		Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Lenvatinib Sandoz 4 mg	Hartkapseln	Capsules (Lenvatinibum 4 mg)	L01EX08
02	Lenvatinib Sandoz 10 mg	Hartkapseln	Capsules (Lenvatinibum 10 mg)	L01EX08

2026	©ywesee GmbH